---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-070671"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2025-08-01T23:59:59+00:00"
generated_at: "2026-05-17T21:48:27.990307+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Adial enters new ATM facility for up to $4.98M; terminates prior HCW Wainwright ATM

## Summary
- New ATM sales agreement with A.G.P./Alliance Global Partners for up to $4,983,000 of common stock.
- Sales agent commission of 3.0% of gross proceeds; expense reimbursement up to $50k initial plus quarterly fees.
- Prior ATM with H.C. Wainwright terminated July 31, 2025; had raised ~$4M net from 2.35M shares.
- Company not obligated to sell shares; sales may be suspended at any time.

## SEC filing metadata
- accession: 0001213900-25-070671
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2025-08-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390025070671/0001213900-25-070671-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390025070671/ea0251183-8k_adial.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-070671
- JSON: https://secwatch.observer/filing/0001213900-25-070671.json
- Plain text: https://secwatch.observer/filing/0001213900-25-070671.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
